FDA has delayed implementation of proposed changes to its definition of “intended use” by one year in the face of significant stakeholder protest.
A final rule published Jan. 9 would have broadened the definition of “intended use” to what is called the “totality...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?